Paroxetine in social phobia.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Clinical Psychiatry

• Publication date

  1996-11-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.V57N1103PMID 8968300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurobiology of Social Phobia

  1999cited by this paper
• Sertraline in social phobia.

  1995cited by this paper
• Sertraline for social phobia: a double-blind, placebo-controlled crossover study.

  1995cited by this paper
• Sertraline in social phobia.

  1994cited by this paper
• Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

  1994cited by this paper
• Fluoxetine efficacy in social phobia.

  1993cited by this paper
• Buspirone in social phobia.

  1993cited by this paper
• Treatment of social phobia with clonazepam and placebo.

  1993cited by this paper
• Fluoxetine in social phobia.

  1992cited by this paper
• Pharmacotherapy of Social Phobia

  1992cited by this paper
• Phenelzine vs atenolol in social phobia. A placebo-controlled comparison.

  1992cited by this paper
• Fluoxetine for the treatment of social phobia.

  1992cited by this paper
• Value of the Fear Questionnaire in Differentiating Agoraphobia and Social Phobia

  1991cited by this paper
• Fluoxetine treatment of social phobia.

  1990cited by this paper
• A pilot study of treatment of social phobia with alprazolam.

  1988cited by this paper
• Alprazolam in the treatment of social phobia.

  1988cited by this paper
• Tranylcypromine in social phobia.

  1988cited by this paper
• Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol.

  1988cited by this paper
• Treatment of Social Phobia with Atenolol

  1985cited by this paper
• Cognitive components of social anxiety.

  1984cited by this paper
• Brief standard self-rating for phobic patients.

  1979cited by this paper
• SOCIAL ADJUSTMENT BY SELF‐REPORT IN A COMMUNITY SAMPLE AND IN PSYCHIATRIC OUTPATIENTS

  1978cited by this paper
• Assessment of social adjustment by patient self-report.

  1976cited by this paper
• Measurement of social-evaluative anxiety.

  1969cited by this paper
• An inventory for measuring depression.

  1961cited by this paper

• Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain

  2020cites this paper
• Acute Fluoxetine Treatment Produce Anxiolytic Effects without Modulating Behaviour Response on Exposure to Forced Swimming Test

  2019cites this paper
• Anxiolytic profile of fluoxetine as monitored following repeated administration in animal rat model of chronic mild stress

  2015cites this paper
• A Review of its Pharmacology and Therapeutic Potential in the Management of Panic Disorder

  2012cites this paper
• Dual modes of extracellular serotonin changes in the rat ventral striatum modulate adaptation to a social stress environment, studied with wireless voltammetry

  2012cites this paper
• Effect of 5-fluorouracil chemotherapy and the potential protective effect of the SSRI antidepressant fluoxetine on memory and neurogenesis in the adult hippocampus

  2010cites this paper
• Pharmacotherapy for social anxiety disorder: an update.

  2009cites this paper
• Prevalence, correlates, disability, and comorbidity of DSM-IV narcissistic personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions.

  2008cites this paper
• Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions.

  2008cites this paper
• Social Anxiety Disorder - A Review of Pharmacological Treatments

  2007cites this paper
• Trastorno de ansiedad social

  2006cites this paper
• Paroxetine: a review.

  2006cites this paper
• Factores asociados a la ansiedad y fobia social

  2006cites this paper
• Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

  2005cites this paper
• IMPAIRMENT IN FACIAL AFFECT RECOGNITION: DEFICIT OR ANXIETY?

  2005cites this paper
• Neurobiologie et pharmacothérapie de la phobie sociale

  2004cites this paper
• [Neurobiology and pharmacotherapy of social phobia].

  2004cites this paper
• WCA Recommendations for the Long-Term Treatment of Social Phobia

  2003cites this paper
• Social phobia.

  2003cites this paper
• Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review

  2003cites this paper
• Differential neurochemical properties of central serotonergic transmission in Roman high‐ and low‐avoidance rats

  2003cites this paper
• Aggiornamenti in PSICHIATRIA supplemento a Heroin Addiction and Related Clinical Problems

  2003cites this paper
• Distribution and morphology of serotonin‐immunoreactive axons in the hippocampal region of the New Zealand white rabbit. I. Area dentata and hippocampus

  2003cites this paper
• Bipolar comorbidity: from diagnostic dilemmas to therapeutic challenge.

  2003cites this paper
• Pharmacotherapy of anxious disorders

  2002cites this paper
• Acute effects of amperozide and paroxetine on social cohesion in male conspecifics.

  2002cites this paper
• Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex

  2002cites this paper
• Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo-controlled paroxetine trials.

  2002cites this paper
• Psychological and Pharmacological Treatments of Social Phobia: A Meta-Analysis

  2001cites this paper
• Symptomatic and functional assessment of social anxiety disorder in adults.

  2001cites this paper
• Management of anxiety disorders: The added challenge of comorbidity

  2001cites this paper
• Antidepressants in social anxiety disorder.

  2001cites this paper
• Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats.

  2000cites this paper
• The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta‐analysis of randomized controlled trials

  2000cites this paper
• Social anxiety disorder/social phobia: epidemiology, diagnosis, neurobiology, and treatment.

  2000cites this paper
• Serotonergic drugs in the treatment of depressive and anxiety disorders

  2000cites this paper
• Fear: The Impact and Treatment of Social Phobia

  2000cites this paper
• Defining an appropriate management strategy for social anxiety disorder

  2000cites this paper
• Current issues in the identification and management of bipolar spectrum disorders in 'special populations'.

  2000cites this paper
• Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors

  2000cites this paper
• Quality of Life in the Anxiety Disorders

  2000cites this paper
• Social anxiety disorder/social phobia: Epidemiology, diagnosis, neurobiology, and treatment

  2000cites this paper
• O tratamento farmacológico da fobia social

  1999cites this paper
• Paroxetine

  1999cites this paper
• A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.

  1999cites this paper
• Nefazodone in social phobia.

  1999cites this paper
• Social Phobia: Issues in Assessment and Management

  1999cites this paper
• Serotonergic agents in the treatment of social phobia in children and adolescents: A case series

  1999cites this paper
• Selective Serotonin Reuptake Inhibitors in the Treatment of Social Phobia

  1999cites this paper
• Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders.

  1999cites this paper
• Axis I comorbidity of borderline personality disorder.

  1998cites this paper
• The broad spectrum of comorbid depression: implications for treatment

  1998cites this paper
• The role of drug therapy in social phobia.

  1998cites this paper
• Fluoxetine in social phobia: An open pilot study

  1998cites this paper
• Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia.

  1998cites this paper
• Pharmacotherapy of social anxiety disorder.

  1998cites this paper
• Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

  1998cites this paper
• The clinical relevance of treating social phobia.

  1998cites this paper
• El espectro amplio de la depresión comórbida: implicaciones para el tratamiento

  1998cites this paper
• Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety.

  1998cites this paper
• Paroxetine

  1997cites this paper
• Assessment and Treatment of Social Phobia

  1997cites this paper
• Social phobia: epidemiology, recognition, and treatment

  1997cites this paper
• Social phobia: long‐term treatment outcome and prediction of response - a moclobemide study

  1997cites this paper